Dr. Ibrahim Abu-Gheida is Chief Medical Officer of Burjeel Cancer Institute and Clinical Director of Radiation Oncology at Burjeel Medical City. From 2023–2025, he also served as Chief Medical Officer of Burjeel Medical City. In 2023, he founded the Emirates Oncology Society Radiation Oncology Work Group and currently serves as its President. He is also a Regional Committee Member of the Radiological Society of North America (RSNA), representing the Middle East and Africa, and serves as ASTRO Ambassador to the UAE.
Dr. Abu-Gheida earned his BS with honors and MD from the American University of Beirut, where he also completed Internal Medicine training and Radiation Oncology residency, serving as Chief Resident. During his training, he participated in a Harvard-affiliated, NIH-funded research program.
He subsequently completed an Advanced Clinical Radiation Oncology Fellowship at Cleveland Clinic and advanced subspecialty training at MD Anderson Cancer Center, focusing on breast, gastrointestinal, and genitourinary cancers.
Dr. Abu-Gheida played a key role in establishing and leading Radiation Oncology at Burjeel Medical City. He has chaired and co-chaired major international oncology meetings, including Best of ASTRO–Dubai and the UAE & GCC Radiation Oncology Conference.
His academic work includes more than 50 peer-reviewed publications in leading journals, including Nature, Journal of Clinical Oncology, and the International Journal of Radiation Oncology, Biology, Physics, as well as multiple medical textbook chapters
Disclosures:
- Employment: Burjeel holdings:Cheif medical officer and clinical director:Employee
- Compensation: Pfizer: Education Meeting Faculty, Honoraria-End Date: to present ;AstraZeneca: Education Meeting Faculty, Honoraria-End Date: to present ;MSD: Speaker's Bureau, Travel Expenses-End Date: 06/20/2025
- Ownership: none
- Leadership: none